{
  "release_id": "a25293eeae6350fb",
  "id": "cardio:ace-inhibitors",
  "owner": "cardio",
  "kind": "drug",
  "slug": "ace-inhibitors",
  "name": "ACE inhibitors",
  "aliases": [
    "ACE inhibitor",
    "Angiotensin-converting enzyme inhibitors"
  ],
  "atlases": [
    "cardio"
  ],
  "summary_plain": "A class of medicines whose main uses are treating high blood pressure and heart failure. MeSH says they work mainly by inhibiting the renin-angiotensin system, and cause mostly widening of blood vessels and a mild loss of salt in the urine without changing the heart rate. The US label read for one ACE inhibitor also lists lowering the risk of death when treatment starts within 24 hours of a heart attack in people whose circulation is stable, and carries a boxed warning that these drugs can cause injury and death to the developing fetus.",
  "summary_technical": "Class page. MeSH descriptor D000806 (Angiotensin-Converting Enzyme Inhibitors, last updated 2026-01-01) is an exact match, and its scope note gives the class description. The label read is the US prescribing label of one brand-name lisinopril tablet (application NDA019777, effective 2025-01-02 in openFDA). It calls the medicine an ACE inhibitor and lists hypertension (adults and pediatric patients 6 years of age and older), adjunct therapy for heart failure and reduction of mortality in a window after acute myocardial infarction. A separate claim records its boxed warning on fetal toxicity; the recipient of that risk is the fetus. One label stands for one product, so other members of the class may list other uses, and no other label was read. This page gives no dose, no trial result and no guideline statement. Medicines of the class that have their own pages are filed under it.",
  "editorial_state": "draft",
  "last_substantive_edit": "2026-11-09",
  "last_evidence_check": "2026-11-09",
  "next_review_due": null,
  "identifiers": [
    {
      "scheme": "mesh",
      "value": "D000806",
      "normalized_value": "D000806",
      "match": "exact",
      "version": "MeSH linked-data descriptor record fetched on 2026-11-09, lastUpdated 2026-01-01; the record states no yearly MeSH release",
      "label": "Angiotensin-Converting Enzyme Inhibitors",
      "from_source": false
    }
  ],
  "navigation": {
    "cardio": {
      "system": [
        "blood-vessels"
      ],
      "condition-area": [
        "hypertension",
        "heart-failure"
      ]
    }
  },
  "payload": {
    "level": "class",
    "mechanism": "MeSH says these drugs exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. A US label explains that the enzyme they block converts angiotensin I to the vasoconstrictor angiotensin II."
  },
  "content_digest": "2a216bbdb6c4bbc95eaccf86fd2a28bfc83992fc469a4dcc9ff33e2b28ece90e",
  "review": {
    "content_digest": "2a216bbdb6c4bbc95eaccf86fd2a28bfc83992fc469a4dcc9ff33e2b28ece90e",
    "current": [],
    "conflicting": [],
    "stale": [],
    "inactive": []
  },
  "claims": [
    {
      "release_id": "a25293eeae6350fb",
      "id": "cardio:claim-fda-zestril-label-boxed-warning",
      "owner": "cardio",
      "subject_entity_id": "cardio:ace-inhibitors",
      "category": "safety",
      "statement": "The same US label of ZESTRIL carries a boxed warning titled fetal toxicity. It says that drugs acting directly on the renin-angiotensin system can cause injury and death to the developing fetus.",
      "context": {
        "id": "cardio:ctx-fda-zestril-label-fetal-risk",
        "label": "The developing fetus, for a person taking an ACE inhibitor during pregnancy, as described in a US label boxed warning",
        "recipient": "fetal",
        "population": "The developing fetus when a pregnant person takes the medicine, as the label boxed warning describes the risk. The warning is not about the person who takes the medicine.",
        "care_setting": "Prescription medicine, as described in the US label",
        "geography": "United States (US drug label)",
        "life_stage_note": "Fetus during pregnancy; the passage read gives no gestational ages",
        "life_stage_terms": null,
        "gestational_age_min_days": null,
        "gestational_age_max_days": null,
        "gestational_age_basis": null,
        "postnatal_age_min_days": null,
        "postnatal_age_max_days": null,
        "gestational_age_status": null,
        "postnatal_age_status": null,
        "followup_description": "Not applicable (label statement)",
        "eligibility": {
          "inclusion": [
            "Pregnancy during which the medicine is taken (risk to the fetus)"
          ],
          "exclusion": []
        }
      },
      "evidence_stage": "not_applicable",
      "certainty": "not_assessed",
      "certainty_method": null,
      "limitations": "This claim records the fetal-risk statement of the label's boxed warning only. The warning also tells prescribers what to do when pregnancy is detected; that instruction is not repeated here. Other warnings, contraindications and interactions of the label were not recorded, and no pregnancy or lactation guidance is given. Labels change, and openFDA's own disclaimer says not to rely on it for decisions about medical care.",
      "editorial_state": "draft",
      "checked_at": "2026-11-09",
      "next_review_due": null,
      "valid_from": null,
      "valid_to": null,
      "citations": [
        {
          "evidence_role": "supports",
          "locator": "results[0].boxed_warning[0]",
          "applicability_note": "The boxed warning title and its fetal-injury statement.",
          "snapshot": {
            "id": "cardio:openfda-label-zestril-2026-11-09",
            "retrieved_at": "2026-11-09T13:17:27Z",
            "content_hash": "19d3c7aeb72318fb767e48d426a1cb5c0715b2f2de82e0028467c20b5e469335",
            "source_effective_date": "2025-01-02",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-zestril",
            "source_type": "regulator",
            "title": "openFDA drug label record for ZESTRIL (lisinopril tablets), Upsher-Smith Laboratories, LLC label: indications and class description",
            "canonical_url": "https://api.fda.gov/drug/label.json?search=set_id:%22838c2d78-d2d8-4981-9ec9-e50ef9e1a5d8%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA drug label record for set id 838c2d78-d2d8-4981-9ec9-e50ef9e1a5d8 (manufacturer Upsher-Smith Laboratories, LLC, application NDA019777), returned on 2026-11-09. The label text is dated 2025-01-02 (effective_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-09, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed at research/snapshots/w4k03-openfda-label-zestril.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "context",
          "locator": "results[0].effective_time",
          "applicability_note": "Effective date of the label text read, 20250102.",
          "snapshot": {
            "id": "cardio:openfda-label-zestril-2026-11-09",
            "retrieved_at": "2026-11-09T13:17:27Z",
            "content_hash": "19d3c7aeb72318fb767e48d426a1cb5c0715b2f2de82e0028467c20b5e469335",
            "source_effective_date": "2025-01-02",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-zestril",
            "source_type": "regulator",
            "title": "openFDA drug label record for ZESTRIL (lisinopril tablets), Upsher-Smith Laboratories, LLC label: indications and class description",
            "canonical_url": "https://api.fda.gov/drug/label.json?search=set_id:%22838c2d78-d2d8-4981-9ec9-e50ef9e1a5d8%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA drug label record for set id 838c2d78-d2d8-4981-9ec9-e50ef9e1a5d8 (manufacturer Upsher-Smith Laboratories, LLC, application NDA019777), returned on 2026-11-09. The label text is dated 2025-01-02 (effective_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-09, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed at research/snapshots/w4k03-openfda-label-zestril.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        }
      ],
      "review": {
        "content_digest": "21b8177acdd80de688f1f206b2ca9112a9be624bfbfb68da83499f075d3e1e86",
        "current": [],
        "conflicting": [],
        "stale": [],
        "inactive": []
      },
      "api_path": "api/v1/claims/cardio--claim-fda-zestril-label-boxed-warning.json"
    },
    {
      "release_id": "a25293eeae6350fb",
      "id": "cardio:claim-fda-zestril-label-indications",
      "owner": "cardio",
      "subject_entity_id": "cardio:ace-inhibitors",
      "category": "descriptive",
      "statement": "The US label of ZESTRIL (lisinopril tablets, Upsher-Smith Laboratories, application NDA019777; the version dated 2025-01-02 in openFDA) calls the medicine an angiotensin converting enzyme (ACE) inhibitor. It lists treating hypertension in adults and pediatric patients 6 years of age and older, adjunct therapy for heart failure (its detailed text says to reduce signs and symptoms of systolic heart failure), and reducing mortality in hemodynamically stable patients within 24 hours of acute myocardial infarction. MeSH describes the class in the same terms, as drugs whose main indications are the treatment of hypertension and heart failure.",
      "context": {
        "id": "cardio:ctx-fda-zestril-label-us",
        "label": "People with hypertension (adults and pediatric patients 6 years and older), heart failure or a recent heart attack, as described in the US label of an ACE inhibitor",
        "recipient": "mixed",
        "population": "Patients described in the indications section of the label: adults and pediatric patients 6 years of age and older with hypertension, patients with systolic heart failure, and hemodynamically stable patients within 24 hours of acute myocardial infarction.",
        "care_setting": "Prescription medicine, as described in the US label",
        "geography": "United States (US drug label)",
        "life_stage_note": "Adults, and for hypertension also pediatric patients 6 years of age and older, as the label states",
        "life_stage_terms": null,
        "gestational_age_min_days": null,
        "gestational_age_max_days": null,
        "gestational_age_basis": null,
        "postnatal_age_min_days": null,
        "postnatal_age_max_days": null,
        "gestational_age_status": null,
        "postnatal_age_status": null,
        "followup_description": "Not applicable (label statement)",
        "eligibility": {
          "inclusion": [
            "Adults and pediatric patients 6 years of age and older with hypertension",
            "Systolic heart failure (adjunct therapy)",
            "Hemodynamically stable patients within 24 hours of acute myocardial infarction"
          ],
          "exclusion": []
        }
      },
      "evidence_stage": "not_applicable",
      "certainty": "not_assessed",
      "certainty_method": null,
      "limitations": "This claim records what one US label says the medicine is indicated for. It is not a finding about how well the medicine works, and no trial result is recorded for it in this atlas. Other ACE inhibitor labels list different uses. The label's contraindications, other warnings, interactions and dosing were not recorded; its boxed warning is recorded in a separate claim. Labels change, and openFDA lists other versions with different dates. openFDA's own disclaimer says not to rely on it for decisions about medical care.",
      "editorial_state": "draft",
      "checked_at": "2026-11-09",
      "next_review_due": null,
      "valid_from": null,
      "valid_to": null,
      "citations": [
        {
          "evidence_role": "supports",
          "locator": "results[0].indications_and_usage[0], 1 INDICATIONS AND USAGE",
          "applicability_note": "The label sentence that calls the medicine an ACE inhibitor and the hypertension, heart failure (systolic heart failure in section 1.2) and acute myocardial infarction uses.",
          "snapshot": {
            "id": "cardio:openfda-label-zestril-2026-11-09",
            "retrieved_at": "2026-11-09T13:17:27Z",
            "content_hash": "19d3c7aeb72318fb767e48d426a1cb5c0715b2f2de82e0028467c20b5e469335",
            "source_effective_date": "2025-01-02",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-zestril",
            "source_type": "regulator",
            "title": "openFDA drug label record for ZESTRIL (lisinopril tablets), Upsher-Smith Laboratories, LLC label: indications and class description",
            "canonical_url": "https://api.fda.gov/drug/label.json?search=set_id:%22838c2d78-d2d8-4981-9ec9-e50ef9e1a5d8%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA drug label record for set id 838c2d78-d2d8-4981-9ec9-e50ef9e1a5d8 (manufacturer Upsher-Smith Laboratories, LLC, application NDA019777), returned on 2026-11-09. The label text is dated 2025-01-02 (effective_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-09, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed at research/snapshots/w4k03-openfda-label-zestril.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "context",
          "locator": "results[0].effective_time",
          "applicability_note": "Effective date of the label text read, 20250102.",
          "snapshot": {
            "id": "cardio:openfda-label-zestril-2026-11-09",
            "retrieved_at": "2026-11-09T13:17:27Z",
            "content_hash": "19d3c7aeb72318fb767e48d426a1cb5c0715b2f2de82e0028467c20b5e469335",
            "source_effective_date": "2025-01-02",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-zestril",
            "source_type": "regulator",
            "title": "openFDA drug label record for ZESTRIL (lisinopril tablets), Upsher-Smith Laboratories, LLC label: indications and class description",
            "canonical_url": "https://api.fda.gov/drug/label.json?search=set_id:%22838c2d78-d2d8-4981-9ec9-e50ef9e1a5d8%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA drug label record for set id 838c2d78-d2d8-4981-9ec9-e50ef9e1a5d8 (manufacturer Upsher-Smith Laboratories, LLC, application NDA019777), returned on 2026-11-09. The label text is dated 2025-01-02 (effective_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-09, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed at research/snapshots/w4k03-openfda-label-zestril.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "supports",
          "locator": "scopeNote.@value",
          "applicability_note": "MeSH scope note: main indications of the class.",
          "snapshot": {
            "id": "cardio:mesh-scope-d000806-2026-10-25",
            "retrieved_at": "2026-10-25T15:27:58Z",
            "content_hash": "e0f6d57f67dfdc38977aa3de8fe4fc3ea23b840a72635886b2966506da249e97",
            "source_effective_date": null,
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:mesh-scope-d000806",
            "source_type": "dataset",
            "title": "MeSH scope note for descriptor D000806 (Angiotensin-Converting Enzyme Inhibitors)",
            "canonical_url": "https://id.nlm.nih.gov/mesh/M0001207",
            "identifiers": [
              {
                "scheme": "mesh",
                "value": "M0001207",
                "normalized_value": "M0001207",
                "match": "exact",
                "version": "id.nlm.nih.gov linked data, preferred concept of descriptor D000806, retrieved 2026-10-25",
                "label": null,
                "from_source": false
              }
            ],
            "publication_date": null,
            "publisher": "U.S. National Library of Medicine",
            "edition": "MeSH linked-data record of the preferred concept M0001207 of descriptor D000806, fetched 2026-10-25. The scope note is on this concept record, not on the descriptor record.",
            "reuse_basis": "The NLM web policies page (sha256 c8b7026b5c3fcfd1b0cb88755077f6a99a5f2159eecd42b0e7d1a5ad9b30ec55, hash only) says works produced by the U.S. government are not subject to copyright protection in the United States and asks users to acknowledge NLM as the source. Source: National Library of Medicine. This copy was fetched on 2026-10-25 and may not reflect the most current data. The raw bytes are committed at research/snapshots/gl-meshc-M0001207.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        }
      ],
      "review": {
        "content_digest": "a13d554c844fe31b2d53d3ecd8a7ade1017363d725fc635a89b5740f11e1ae4b",
        "current": [],
        "conflicting": [],
        "stale": [],
        "inactive": []
      },
      "api_path": "api/v1/claims/cardio--claim-fda-zestril-label-indications.json"
    }
  ],
  "decisions": [],
  "milestones": [],
  "relationships": {
    "outgoing": [
      {
        "predicate": "evaluated_for",
        "label": "A US label lists treating high blood pressure as an indication",
        "clinical_claim_not_fact": true,
        "family": "clinical",
        "other_entity_id": "core:hypertension",
        "other_entity_in_atlas": true,
        "claim_id": "cardio:claim-fda-zestril-label-indications",
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "evaluated_for",
        "label": "A US label lists adjunct therapy for heart failure as an indication",
        "clinical_claim_not_fact": true,
        "family": "clinical",
        "other_entity_id": "cardio:heart-failure",
        "other_entity_in_atlas": true,
        "claim_id": "cardio:claim-fda-zestril-label-indications",
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "evaluated_for",
        "label": "A US label lists a mortality-reduction use after a heart attack",
        "clinical_claim_not_fact": true,
        "family": "clinical",
        "other_entity_id": "cardio:myocardial-infarction",
        "other_entity_in_atlas": true,
        "claim_id": "cardio:claim-fda-zestril-label-indications",
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "related_to",
        "label": "A US label of the class lists reducing signs and symptoms of systolic heart failure",
        "clinical_claim_not_fact": false,
        "family": "navigation",
        "other_entity_id": "cardio:hfref",
        "other_entity_in_atlas": true,
        "claim_id": "cardio:claim-fda-zestril-label-indications",
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "related_to",
        "label": "Reading path on high blood pressure that names this class; a US label of the class lists high blood pressure",
        "clinical_claim_not_fact": false,
        "family": "navigation",
        "other_entity_id": "cardio:reading-path-high-bp",
        "other_entity_in_atlas": true,
        "claim_id": "cardio:claim-fda-zestril-label-indications",
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "related_to",
        "label": "Patient guide on high blood pressure that names this class; a US label of the class lists high blood pressure",
        "clinical_claim_not_fact": false,
        "family": "navigation",
        "other_entity_id": "cardio:guide-new-high-blood-pressure",
        "other_entity_in_atlas": true,
        "claim_id": "cardio:claim-fda-zestril-label-indications",
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "related_to",
        "label": "Blood pressure lowering medicine, the care strategy",
        "clinical_claim_not_fact": false,
        "family": "navigation",
        "other_entity_id": "cardio:bp-lowering-medicine",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "related_to",
        "label": "Heart failure medicine regimen",
        "clinical_claim_not_fact": false,
        "family": "navigation",
        "other_entity_id": "cardio:hfref-four-medicine-regimen",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "part_of",
        "label": "Files under this front",
        "clinical_claim_not_fact": false,
        "family": "navigation",
        "other_entity_id": "cardio:front-medicines",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": null,
        "primary": true,
        "role": null,
        "valid_from": null,
        "valid_to": null
      }
    ],
    "incoming": [
      {
        "predicate": "subtype_of",
        "label": "Has subtype",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:enalapril",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:rxclass-3827-2026-11-09",
          "locator": "rxclassDrugInfoList.rxclassDrugInfo[1].rxclassMinConceptItem.className"
        },
        "primary": true,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "subtype_of",
        "label": "Has subtype",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:lisinopril",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:rxclass-29046-2026-11-09",
          "locator": "rxclassDrugInfoList.rxclassDrugInfo[1].rxclassMinConceptItem.className"
        },
        "primary": true,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "subtype_of",
        "label": "Has subtype",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ramipril",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:rxclass-35296-2026-11-09",
          "locator": "rxclassDrugInfoList.rxclassDrugInfo[1].rxclassMinConceptItem.className"
        },
        "primary": true,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "related_to",
        "label": "Related to",
        "clinical_claim_not_fact": false,
        "family": "navigation",
        "other_entity_id": "cardio:ranolazine",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct04330300",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct04330300-2020-06-30",
          "locator": "protocolSection.armsInterventionsModule.interventions[2].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      }
    ]
  },
  "page_path": "drugs/ace-inhibitors/",
  "context_path": "api/v1/context/cardio--ace-inhibitors.md"
}
